Vir Biotechnology Overview
Vir Biotechnology Target Price
Analysts' 12-month price predictions for VIR.
Share Price
$5.43
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-01-09 | Morgan StanleyMichael Ulz | $20 |  268.3% upside |  |
| 2024-08-02 | BarclaysGena Wang | $28 | 415.7% upside | |
| 2024-06-05 | Morgan StanleyMichael Ulz | $15 | 176.2% upside | |
| 2024-05-21 | BarclaysGena Wang | $27 | 397.2% upside | |
| 2023-02-21 | Goldman SachsPaul Choi | $28.38 | 422.7% upside | |
| 2022-05-06 | NeedhamJoseph Stringer | $35 | 544.6% upside | |